BIO-key Intl (NASDAQ:BKYI) will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate BIO-key Intl to report an earnings per share (EPS) of $-0.58.
The market awaits BIO-key Intl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at BIO-key Intl's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | ||||
| EPS Actual | -1 | -0.32 | -0.25 | -1.44 |
| Price Change % | -10.0% | 9.0% | -7.000000000000001% | -26.0% |
Market Performance of BIO-key Intl's Stock
Shares of BIO-key Intl were trading at $1.05 as of November 12. Over the last 52-week period, shares are down 64.59%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for BIO-key Intl visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
